SoftBank OpenAI Investment Boosts Q2 Profit

SoftBank OpenAI investment powered a Vision Fund valuation gain that lifted Q2 net profit to $16.6 billion while shares fell amid AI-bubble concerns.

November 11, 2025·2 min read
View all news articles
Flat-vector cover of a single server tower symbolizing SoftBank OpenAI investment and Vision Fund gain

KEY TAKEAWAYS

  • Vision Fund gains lifted Q2 net profit to $16.6 billion.
  • ¥3.5 trillion Vision Fund gain included ¥2.16 trillion attributable to OpenAI.
  • SoftBank plans a second closing to invest $22.5 billion via SVF2 in December 2025.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

SoftBank Group (SFTBF, SFTBY) said on Nov. 11, 2025, that its OpenAI investment helped drive a record quarterly profit, as a Vision Fund valuation gain lifted results even while shares slid amid investor concern about an AI bubble.

Vision Fund Valuation Drives Record Profit

SoftBank reported a net profit of ¥2.5 trillion ($16.6 billion) for the quarter ended Sept. 30, 2025, far exceeding an LSEG consensus of ¥207 billion. The gain was largely driven by a ¥3.5 trillion Vision Fund valuation increase, with ¥2.16 trillion attributable to OpenAI holdings. This included an unrealized valuation gain of ¥980.5 billion and a derivative gain of ¥1.18 trillion from the OpenAI Forward Contract, reflecting fair-value marks rather than realized sales.

Operationally, revenue rose 7.7% year over year to ¥3.74 trillion. Non-telecom businesses accounted for 63% of revenue, up from 47% a year earlier. Operating income reached ¥628.9 billion, while SoftBank Corp.’s segment net income was ¥348.8 billion. Management continues to shift strategically toward AI and cloud services, including joint ventures linked to OpenAI in Japan.

OpenAI Follow-On Investment and Outlook

On March 31, 2025, SoftBank signed a definitive agreement to invest up to $40 billion in OpenAI Global, with $10 billion syndicated to co-investors and $30 billion retained by SoftBank. The first closing in April 2025 provided $10 billion, with $7.5 billion invested by SoftBank Vision Fund 2 (SVF2) and $2.5 billion syndicated. An amended agreement in October 2025 allows SoftBank to make the full second-closing investment regardless of certain conditions.

OpenAI completed a recapitalization on Oct. 28, 2025, transitioning to OpenAI Group PBC. SoftBank plans a second closing in December 2025 to invest an additional $22.5 billion via SVF2, subject to syndication and agreed conditions. Since inception, SVF1 has generated $32.8 billion in gains, while SVF2 carries a $9.1 billion cumulative loss excluding recent OpenAI gains.

Despite the record profit, SoftBank’s shares declined amid investor concerns about the sustainability of AI valuations and a potential “AI bubble.” The company’s filings disclosed no material regulatory impediments as of Nov. 11, 2025.

“Investment gains totaling ¥2,156.7 billion from the investment in OpenAI,” SoftBank said in its Q2 financial report. “This includes an unrealized valuation gain of ¥980.5 billion resulting from an increase in the fair value of the equity interests and a derivative gain of ¥1,176.2 billion arising from an increase in the fair value of the OpenAI Forward Contract.”

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Read other top news stories

U.S.-Switzerland Trade Deal Lowers Tariffs

U.S.-Switzerland trade deal eases pressure on Swiss watch and pharmaceutical exporters and reduces a near-term sales and pricing headwind for traders.

Ron Baron Tesla Sees $2,500 Target, Holds Stakes

Ron Baron Tesla reaffirmed a lifetime hold and backed Musk's pay package, spotlighting governance and focusing investors on his $2,500 Tesla price target.

StubHub Q3 Earnings: Stock Falls After Guidance Withheld

StubHub Q3 earnings showed revenue growth but a large IPO-related net loss and no Q4 guidance, prompting a steep share selloff and pressured positioning.

Lundbeck Bid for Avadel Tops Alkermes Deal

Lundbeck Bid for Avadel raises takeover stakes by topping Alkermes' signed agreement and could force matching or renegotiation that reshapes deal certainty

Merck To Acquire Cidara Therapeutics

Merck to acquire Cidara strengthens its antiviral and respiratory pipeline ahead of Keytruda patent expiry and shifts near-term trader positioning.

Walmart CEO Transition Names John Furner

Walmart CEO transition names John Furner; the board appointment and handover aim to preserve operational continuity and limit governance uncertainty.